11 insiders reported 24 Form 4 transactions for BridgeBio Oncology Therapeutics, Inc. (BBOT) over the past 18 months (most recent 2026-07-06). Recent activity: Chen Bihua (Director) Sell 4.5M shares, Cobo Marc (Principal Accounting Officer) Sell 125 shares, Ben Yong (Chief Med & Dev Officer) Sell 1,047 shares, Beltran Pedro (President and CEO) Sell 1,047 shares, Elmelech Idan (COO & Principal Financial Ofcr) Sell 343 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | Chen Bihua | Director | Sell | 4.5M | $0 |
| 2026-07-06 | Cobo Marc | Principal Accounting Officer | Sell | 125 | $975 |
| 2026-07-06 | Ben Yong | Chief Med & Dev Officer | Sell | 1,047 | $8,167 |
| 2026-07-06 | Beltran Pedro | President and CEO | Sell | 1,047 | $8,167 |
| 2026-07-06 | Elmelech Idan | COO & Principal Financial Ofcr | Sell | 343 | $2,675 |
| 2026-07-06 | Chen Bihua | Director | Buy | 2.7M | $0 |
| 2026-07-06 | Chen Bihua | Director | Buy | 1.7M | $0 |
| 2026-07-06 | Chen Bihua | Director | Buy | 130,865 | $0 |
| 2026-03-12 | Beltran Pedro | Chief Scientific Officer | Buy | 46,670 | $0 |
| 2026-03-12 | Mehra Uneek | Chief Financial Officer | Buy | 23,330 | $0 |
| 2026-03-12 | Ben Yong | Chief Med & Dev Officer | Buy | 46,670 | $0 |
| 2025-10-16 | BridgeBio Pharma LLC | Insider | Buy | 784,720 | $0 |
| 2025-10-16 | BridgeBio Pharma, Inc. | Insider | Buy | 784,720 | $0 |
| 2025-08-13 | Chen Bihua | Director | Buy | 4.2M | $0 |
| 2025-08-13 | Chen Bihua | Director | Sell | 152,940 | $0 |
| 2025-08-13 | Chen Bihua | Director | Buy | 760,496 | $8.2M |
| 2025-08-13 | Chen Bihua | Director | Buy | 639,110 | $6.9M |
| 2025-08-13 | Chen Bihua | Director | Buy | 5.6M | $60.0M |
| 2025-08-13 | Chen Bihua | Director | Buy | 1.9M | $0 |
| 2025-08-13 | Chen Bihua | Director | Buy | 1.8M | $0 |
| 2025-08-13 | Chen Bihua | Director | Buy | 284,571 | $0 |
| 2025-08-11 | Schmid John P. | Insider | Buy | 30,000 | $0 |
| 2025-08-11 | Holman Albert A III | Insider | Buy | 30,000 | $0 |
| 2025-08-11 | McKenna Mark C. | Insider | Buy | 30,000 | $0 |
Source: SEC Form 4 filings · as of 2026-07-06